Preparation method of 5-(piperazine-1-group) benzofuran-2-carboxylic acid ethyl ester
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANDONG ZOUPING DAZHAN NEW MATERIALS
- Publication Date
- 2012-08-15
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a preparation method of ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate, which is an important intermediate for synthesizing vilazodone hydrochloride. Background technique
[0002] Vilazodone hydrochloride was approved by the US Food and Drug Administration in January 2011 for the treatment of moderate to severe depression in adults. Clinical trial data show that its curative effect is significantly better than that of placebo, with good tolerance and less adverse reactions.
[0003] 5-(piperazin-1-yl) ethyl benzofuran-2-carboxylate is the key intermediate of synthetic vilazodone hydrochloride, and a kind of its synthetic method is announced in U.S. Patent No. 5,723,614 as follows:
[0004]
[0005] In this method, ethyl 5-aminobenzofuran-2-carboxylate is used as raw material and N,N-bis(2-chloroethyl)amine to react with stirring for 10 hours to prepare 5-(piperazin-1-yl)benzo Ethyl furan-2-carboxylate, but did not give a...